2019
DOI: 10.1016/j.mcna.2019.05.006
|View full text |Cite
|
Sign up to set email alerts
|

Stroke Prevention in Atrial Fibrillation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(14 citation statements)
references
References 78 publications
0
14
0
Order By: Relevance
“…AF independently increases risk of stroke by 4-5-fold (Zhang et al, 2019). Oral anticoagulants reduce risk of stroke by about twothirds in AF patients (Mtwesi and Amit, 2019). Warfarin is still the first-choice drug for the prevention of stroke in many types of AF (January et al, 2019).…”
Section: Efficacy and Safety During Follow-upmentioning
confidence: 99%
See 1 more Smart Citation
“…AF independently increases risk of stroke by 4-5-fold (Zhang et al, 2019). Oral anticoagulants reduce risk of stroke by about twothirds in AF patients (Mtwesi and Amit, 2019). Warfarin is still the first-choice drug for the prevention of stroke in many types of AF (January et al, 2019).…”
Section: Efficacy and Safety During Follow-upmentioning
confidence: 99%
“…Oral anticoagulants reduce the risk of stroke by two-thirds in AF patients (Mtwesi and Amit, 2019). However, oral anticoagulants undergo varying degrees of kidney clearance, and are associated with a higher risk of bleeding in CKD patients (Shin et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…Management of vascular risk factors (hypertension, hyperlipidemia, diabetes, smoking, new atrial fibrillation and other arrhythmias) is critical, and the use of antiplatelet drugs (aspirin, clopidogrel, etc.) and anticoagulants is recommended according to the stroke prevention guidelines [8,9]. In addition, the use of angiotensin-converting enzyme inhibitors and diuretics can delay the progression of white matter changes in patients with stroke [10].…”
Section: Introductionmentioning
confidence: 99%
“…Management of vascular risk factors (hypertension, hyperlipidemia, diabetes, smoking, new atrial brillation and other arrhythmias) is critical, the use of antiplatelet drugs (aspirin, clopidogrel, etc.) and anticoagulants is selected according to the stroke prevention guidelines [8,9]. In addition, the use of angiotensin-converting enzyme inhibitors and diuretics can delay the progress of white matter changes in patients with stroke [10].…”
Section: Introductionmentioning
confidence: 99%